Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients

Critically ill patients often experience acute kidney injury and the need for renal replacement therapy in the course of their treatment in an intensive care unit (ICU). These patients are at an increased risk for candidiasis. Although there have been several reports of micafungin disposition during...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Vossen, M. G., Knafl, D., Haidinger, M., Lemmerer, R., Unger, M., Pferschy, S., Lamm, W., Maier-Salamon, A., Jäger, W., Thalhammer, F.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527635/
https://ncbi.nlm.nih.gov/pubmed/28584142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02425-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars